Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

HES 130-0.4 × CNS × 1 year × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Interventions

Temozolomide 145 Magnetic Resonance Spectroscopy 112 Radiotherapy 84 Specimen Handling 74 Radiosurgery 62 pembrolizumab 48 Cyclophosphamide 46 Nivolumab 45 Radiation 43 Bevacizumab 35 Carboplatin 29 Biopsy 28 Irinotecan 22 Ipilimumab 22 Etoposide 22 Blood Specimen Collection 20 Cisplatin 19 dinutuximab 18 Vincristine 18 Lomustine 18 Radiotherapy, Intensity-Modulated 17 X-Rays 16 Surgical Procedures, Operative 16 Topotecan 15 Pemetrexed 15 Granulocyte-Macrophage Colony-Stimulating Factor 15 fludarabine 14 abemaciclib 14 sargramostim 13 atezolizumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07476404 2026-03-17

GM-HES

Chiang Mai University

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡